SLXN Stock Price | Biomotion Sciences Ordinary Shares P/E, Revenue, EPS, & Forecasts

Biomotion Sciences Ordinary Shares • SLXN

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Biomotion Sciences Ordinary Shares

Ticker

SLXN

Trading on

NASDAQ

ISIN

KYG1281K1067

Industry

Biotechnology

Sector

Healthcare

CEO

Ilan Hadar M.B.A.

Headquarters

The Goldyne Savad Inst. of Gene Therapy, Jerusalem, undefined, Israel, 9112001

Employees

Website

https://silexion.com

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Metrics

BasicAdvanced

Market cap

$9.9M

P/E ratio

EPS

-$30.78

Dividend Yield

0.00%

Beta

-0.07

Forward P/E ratio

EBIDTA

$-12.5M

Ex dividend date

Price & volume

Market cap

$9.9M

Average daily volume

0.1M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

Price to book

98.23

Earnings

EPS

-$30.78

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-12.5M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

-0.07

52-week High

$63.45

52-week Low

$2.85

50-day moving average

$4.50

200-day moving average

$11.90

Short ratio

0.37

Short %

4.94%

Management effectiveness

ROE (TTM)

-116.66%

ROA (TTM)

-193.54%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

0.00%

Share stats

Outstanding Shares

3.1M

Float

0.4M

Insiders %

4.77%

Institutions %

9.26%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$24.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$274.05

-$14.85

-1,745.45%

Q3 • 24Missed

-$311.40

-$14.70

-2,018.37%

Q4 • 24Missed

-$0.26

Q1 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-1.7M

-∞%

Q1 • 25

$0M

$-2.5M

-∞%

Q2 • 25

NaN%

44.27%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$8.3M

$5.7M

68.87%

Q1 • 25

$5.8M

$5.7M

97.93%

Q2 • 25

-30.22%

-0.79%

42.19%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-2.5M

$-0M

$7.4M

$-2.5M

Q1 • 25

$-2.5M

$-0M

$-0.2M

$-2.5M

Q2 • 25

2.20%

-83.33%

-102.62%

1.99%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Biomotion Sciences Ordinary Shares share?

Biomotion Sciences Ordinary Shares shares are currently traded for undefined per share.

How many shares does Biomotion Sciences Ordinary Shares have?

Biomotion Sciences Ordinary Shares currently has 3.1M shares.

Does Biomotion Sciences Ordinary Shares pay dividends?

No, Biomotion Sciences Ordinary Shares doesn't pay dividends.

What is Biomotion Sciences Ordinary Shares 52 week high?

Biomotion Sciences Ordinary Shares 52 week high is $63.45.

What is Biomotion Sciences Ordinary Shares 52 week low?

Biomotion Sciences Ordinary Shares 52 week low is $2.85.

What is the 200-day moving average of Biomotion Sciences Ordinary Shares?

Biomotion Sciences Ordinary Shares 200-day moving average is $11.90.

Who is Biomotion Sciences Ordinary Shares CEO?

The CEO of Biomotion Sciences Ordinary Shares is Ilan Hadar M.B.A..

How many employees Biomotion Sciences Ordinary Shares has?

Biomotion Sciences Ordinary Shares has 11 employees.

What is the market cap of Biomotion Sciences Ordinary Shares?

The market cap of Biomotion Sciences Ordinary Shares is $9.9M.

What is the P/E of Biomotion Sciences Ordinary Shares?

The current P/E of Biomotion Sciences Ordinary Shares is null.

What is the EPS of Biomotion Sciences Ordinary Shares?

The EPS of Biomotion Sciences Ordinary Shares is -$30.78.

What is the PEG Ratio of Biomotion Sciences Ordinary Shares?

The PEG Ratio of Biomotion Sciences Ordinary Shares is null.

What do analysts say about Biomotion Sciences Ordinary Shares?

According to the analysts Biomotion Sciences Ordinary Shares is considered a buy.